Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD55 Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch CD55 in FACS und IP. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN1106464

Kurzübersicht für CD55 Antikörper (ABIN1106464)

Target

Alle CD55 Antikörper anzeigen
CD55 (Complement Decay-Accelerating Factor (CD55))

Reaktivität

  • 132
  • 33
  • 7
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
Human

Wirt

  • 92
  • 66
  • 6
  • 5
  • 3
  • 1
  • 1
  • 1
Maus

Klonalität

  • 110
  • 63
  • 2
Monoklonal

Konjugat

  • 81
  • 18
  • 16
  • 13
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CD55 Antikörper ist unkonjugiert

Applikation

  • 98
  • 95
  • 42
  • 36
  • 36
  • 23
  • 17
  • 14
  • 14
  • 14
  • 14
  • 4
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunoprecipitation (IP)

Klon

2C6
  • Kreuzreaktivität (Details)

    Species reactivity (tested):Human

    Aufreinigung

    Protein A agarose

    Immunogen

    Human adenocarcinoma cell line (PC3)

    Isotyp

    IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    PBS containing 50 % glycerol, pH 7.2. No preservative is contained.

    Konservierungsmittel

    Without preservative

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target

    CD55 (Complement Decay-Accelerating Factor (CD55))

    Andere Bezeichnung

    CD55 / DAF

    Hintergrund

    CD55, also known as decay-accelerating factor (DAF), is a GPI-anchored membrane inhibitor of complement. It inhibits complement activation by interfering with the function of C3 and C5 convertases in both the classical and alternative pathways. CD55 is expressed on most cells to protect them from complement-mediated attack. CD55 and other membrane complement regulatory proteins (CD46 and CD59) are frequently overexpressed on cancer cells, possibly as a mechanism for cancer cells to overcome lysis by complement. Virus-receptor interactions have been elucidated for several viruses that use CD55 as an adhesion or invasion receptor, including enterovirus, echovirus, and coxsackie B virus. Moreover, CD55 also interacts with an epidermal growth factor-seven-span transmembrane (EGF-TM7) receptor, CD97. CD97 antigen becomes immediately up-regulated on most leukocytes during activation and is constitutively expressed by macrophages, dendritic cells, and some epithelial tumors.Synonyms: Complement decay-accelerating factor

    Gen-ID

    9606

    UniProt

    P08174

    Pathways

    Komplementsystem, Regulation of Leukocyte Mediated Immunity
Sie sind hier:
Chat with us!